{
  "id": "PMID:28007986-Falik_Zaccai-2017-PLAA-A-VI3",
  "subject": {
    "id": "A-VI3",
    "timeAtLastEncounter": {
      "age": {
        "iso8601duration": "P4M"
      }
    },
    "sex": "FEMALE"
  },
  "phenotypicFeatures": [
    {
      "type": {
        "id": "HP:0012448",
        "label": "Delayed myelination"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:28007986",
            "description": "Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy"
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0002808",
        "label": "Kyphosis"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:28007986",
            "description": "Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy"
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0000998",
        "label": "Hypertrichosis"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:28007986",
            "description": "Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy"
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0007377",
        "label": "Abnormality of somatosensory evoked potentials"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:28007986",
            "description": "Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy"
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0001838",
        "label": "Rocker bottom foot"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:28007986",
            "description": "Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy"
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0011922",
        "label": "Abnormal activity of mitochondrial respiratory chain"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:28007986",
            "description": "Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy"
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0001371",
        "label": "Flexion contracture"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:28007986",
            "description": "Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy"
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0000768",
        "label": "Pectus carinatum"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:28007986",
            "description": "Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy"
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0009051",
        "label": "Increased muscle glycogen content"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:28007986",
            "description": "Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy"
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0001382",
        "label": "Joint hypermobility"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:28007986",
            "description": "Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy"
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0000253",
        "label": "Progressive microcephaly"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:28007986",
            "description": "Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy"
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0012444",
        "label": "Brain atrophy"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:28007986",
            "description": "Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy"
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0012713",
        "label": "Moderate hearing impairment"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:28007986",
            "description": "Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy"
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0003487",
        "label": "Babinski sign"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:28007986",
            "description": "Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy"
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0001508",
        "label": "Failure to thrive"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:28007986",
            "description": "Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy"
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0007410",
        "label": "Palmoplantar hyperhidrosis"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:28007986",
            "description": "Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy"
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0001250",
        "label": "Seizure"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:28007986",
            "description": "Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy"
          }
        }
      ]
    }
  ],
  "interpretations": [
    {
      "id": "interpretation-id",
      "progressStatus": "SOLVED",
      "diagnosis": {
        "disease": {
          "id": "OMIM:617527",
          "label": "Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies"
        },
        "genomicInterpretations": [
          {
            "subjectOrBiosampleId": "A-VI3",
            "interpretationStatus": "CAUSATIVE",
            "variantInterpretation": {
              "variationDescriptor": {
                "id": "variant-1",
                "geneContext": {
                  "valueId": "NCBIGene:9373",
                  "symbol": "PLAA"
                },
                "vcfRecord": {
                  "genomeAssembly": "GRCh37",
                  "chrom": "9",
                  "pos": "26905643",
                  "ref": "G",
                  "alt": "A"
                },
                "moleculeContext": "genomic",
                "allelicState": {
                  "id": "GENO:0000136",
                  "label": "homozygous"
                }
              }
            }
          }
        ]
      }
    }
  ],
  "diseases": [
    {
      "term": {
        "id": "OMIM:617527",
        "label": "Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies"
      }
    }
  ],
  "metaData": {
    "created": "2024-03-31T18:44:16.392478942Z",
    "createdBy": "Hpo Case Annotator : 1.0.14-SNAPSHOT",
    "submittedBy": "UNC:biocuration",
    "resources": [
      {
        "id": "hp",
        "name": "human phenotype ontology",
        "url": "http://purl.obolibrary.org/obo/hp.owl",
        "version": "2018-03-08",
        "namespacePrefix": "HP",
        "iriPrefix": "http://purl.obolibrary.org/obo/HP_"
      },
      {
        "id": "pato",
        "name": "Phenotype And Trait Ontology",
        "url": "http://purl.obolibrary.org/obo/pato.owl",
        "version": "2018-03-28",
        "namespacePrefix": "PATO",
        "iriPrefix": "http://purl.obolibrary.org/obo/PATO_"
      },
      {
        "id": "geno",
        "name": "Genotype Ontology",
        "url": "http://purl.obolibrary.org/obo/geno.owl",
        "version": "19-03-2018",
        "namespacePrefix": "GENO",
        "iriPrefix": "http://purl.obolibrary.org/obo/GENO_"
      },
      {
        "id": "eco",
        "name": "Evidence and Conclusion Ontology",
        "url": "http://purl.obolibrary.org/obo/eco.owl",
        "version": "2018-11-10",
        "namespacePrefix": "ECO",
        "iriPrefix": "http://purl.obolibrary.org/obo/ECO_"
      },
      {
        "id": "omim",
        "name": "Online Mendelian Inheritance in Man",
        "url": "https://www.omim.org",
        "version": "n/a",
        "namespacePrefix": "OMIM",
        "iriPrefix": "n/a"
      }
    ],
    "phenopacketSchemaVersion": "2.0",
    "externalReferences": [
      {
        "id": "PMID:28007986",
        "description": "Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy"
      }
    ]
  }
}